BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37710961)

  • 1. Gain-of-function MYCN causes a megalencephaly-polydactyly syndrome manifesting mirror phenotypes of Feingold syndrome.
    Nishio Y; Kato K; Tran Mau-Them F; Futagawa H; Quélin C; Masuda S; Vitobello A; Otsuji S; Shawki HH; Oishi H; Thauvin-Robinet C; Takenouchi T; Kosaki K; Takahashi Y; Saitoh S
    HGG Adv; 2023 Oct; 4(4):100238. PubMed ID: 37710961
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Kato K; Miya F; Hamada N; Negishi Y; Narumi-Kishimoto Y; Ozawa H; Ito H; Hori I; Hattori A; Okamoto N; Kato M; Tsunoda T; Kanemura Y; Kosaki K; Takahashi Y; Nagata KI; Saitoh S
    J Med Genet; 2019 Jun; 56(6):388-395. PubMed ID: 30573562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proximal variants in CCND2 associated with microcephaly, short stature, and developmental delay: A case series and review of inverse brain growth phenotypes.
    Pirozzi F; Lee B; Horsley N; Burkardt DD; Dobyns WB; Graham JM; Dentici ML; Cesario C; Schallner J; Porrmann J; Di Donato N; Sanchez-Lara PA; Mirzaa GM
    Am J Med Genet A; 2021 Sep; 185(9):2719-2738. PubMed ID: 34087052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycn regulates intestinal development through ribosomal biogenesis in a zebrafish model of Feingold syndrome 1.
    Li YF; Cheng T; Zhang YJ; Fu XX; Mo J; Zhao GQ; Xue MG; Zhuo DH; Xing YY; Huang Y; Sun XZ; Wang D; Liu X; Dong Y; Zhu XS; He F; Ma J; Chen D; Jin X; Xu PF
    PLoS Biol; 2022 Nov; 20(11):e3001856. PubMed ID: 36318514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal mosaicism underlies the inheritance of a rare germline AKT3 variant which is responsible for megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome in two Roma half-siblings.
    Szalai R; Melegh BI; Till A; Ripszam R; Csabi G; Acharya A; Schrauwen I; Leal SM; Komoly S; Kosztolanyi G; Hadzsiev K
    Exp Mol Pathol; 2020 Aug; 115():104471. PubMed ID: 32446860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and molecular characterizations of 11 new patients with type 1 Feingold syndrome: Proposal for selecting diagnostic criteria and further genetic testing in patients with severe phenotype.
    Tedesco MG; Lonardo F; Ceccarini C; Cesarano C; Digilio MC; Magliozzi M; Rogaia D; Mencarelli A; Leoni C; Piscopo C; Imperatore V; Falco MT; Fontana P; Nardone AM; Novelli A; Troiani S; Seri M; Prontera P
    Am J Med Genet A; 2021 Apr; 185(4):1204-1210. PubMed ID: 33442900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype-phenotype correlations in MYCN-related Feingold syndrome.
    Marcelis CL; Hol FA; Graham GE; Rieu PN; Kellermayer R; Meijer RP; Lugtenberg D; Scheffer H; van Bokhoven H; Brunner HG; de Brouwer AP
    Hum Mutat; 2008 Sep; 29(9):1125-32. PubMed ID: 18470948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mutation in MYCN gene causing congenital absence of the flexor pollicis longus tendon as an unusual presentation of Feingold syndrome 1.
    Peleg A; Kurolap A; Sagi-Dain L; Larom-Khan G; Adir V; Mory A; Paperna T; Shuldiner AR; Gonzaga-Jauregui C; Adir N; Baris Feldman H; Wollstein R
    Clin Dysmorphol; 2021 Apr; 30(2):71-75. PubMed ID: 32925198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct molecular pathways mediate Mycn and Myc-regulated miR-17-92 microRNA action in Feingold syndrome mouse models.
    Mirzamohammadi F; Kozlova A; Papaioannou G; Paltrinieri E; Ayturk UM; Kobayashi T
    Nat Commun; 2018 Apr; 9(1):1352. PubMed ID: 29636449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Features of Feingold syndrome 1 dominate in subjects with 2p deletions including MYCN.
    Burnside RD; Molinari S; Botti C; Brooks SS; Chung WK; Mehta L; Schwartz S; Papenhausen P
    Am J Med Genet A; 2018 Sep; 176(9):1956-1963. PubMed ID: 30088856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence of Esophageal Atresia With Tracheoesophageal Fistula in Siblings From Three-Generation Family Affected by Variable Expressivity
    Klaniewska M; Toczewski K; Rozensztrauch A; Bloch M; Dzielendziak A; Gasperowicz P; Slezak R; Ploski R; Rydzanicz M; Smigiel R; Patkowski D
    Front Pediatr; 2021; 9():783553. PubMed ID: 34926353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferation and Survival of Embryonic Sympathetic Neuroblasts by MYCN and Activated ALK Signaling.
    Kramer M; Ribeiro D; Arsenian-Henriksson M; Deller T; Rohrer H
    J Neurosci; 2016 Oct; 36(40):10425-10439. PubMed ID: 27707976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYCN haploinsufficiency is associated with reduced brain size and intestinal atresias in Feingold syndrome.
    van Bokhoven H; Celli J; van Reeuwijk J; Rinne T; Glaudemans B; van Beusekom E; Rieu P; Newbury-Ecob RA; Chiang C; Brunner HG
    Nat Genet; 2005 May; 37(5):465-7. PubMed ID: 15821734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Megalencephaly secondary to a novel germline missense variant p.Asp322Tyr in AKT3 associated with growth hormone deficiency and central hypothyroidism: A case report.
    Renard E; Bonnet C; Di Patrizio M; Schmitt E; Madkaud AC; Chabot C; Kuchenbuch M; Lambert L
    Am J Med Genet A; 2024 Jul; 194(7):e63585. PubMed ID: 38459620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissection of the MYCN locus in Feingold syndrome and isolated oesophageal atresia.
    Cognet M; Nougayrede A; Malan V; Callier P; Cretolle C; Faivre L; Genevieve D; Goldenberg A; Heron D; Mercier S; Philip N; Sigaudy S; Verloes A; Sarnacki S; Munnich A; Vekemans M; Lyonnet S; Etchevers H; Amiel J; de Pontual L
    Eur J Hum Genet; 2011 May; 19(5):602-6. PubMed ID: 21224895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Megalencephaly syndromes and activating mutations in the PI3K-AKT pathway: MPPH and MCAP.
    Mirzaa GM; Rivière JB; Dobyns WB
    Am J Med Genet C Semin Med Genet; 2013 May; 163C(2):122-30. PubMed ID: 23592320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtype-specific FBXW7 mutation and MYCN copy number gain in Wilms' tumor.
    Williams RD; Al-Saadi R; Chagtai T; Popov S; Messahel B; Sebire N; Gessler M; Wegert J; Graf N; Leuschner I; Hubank M; Jones C; Vujanic G; Pritchard-Jones K; ;
    Clin Cancer Res; 2010 Apr; 16(7):2036-45. PubMed ID: 20332316
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Muñoz-Martín N; Sierra R; Schimmang T; Villa Del Campo C; Torres M
    Development; 2019 Feb; 146(3):. PubMed ID: 30642836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay between MycN and c-Myc regulates radioresistance and cancer stem cell phenotype in neuroblastoma upon glutamine deprivation.
    Le Grand M; Mukha A; Püschel J; Valli E; Kamili A; Vittorio O; Dubrovska A; Kavallaris M
    Theranostics; 2020; 10(14):6411-6429. PubMed ID: 32483461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Megalencephaly syndromes: exome pipeline strategies for detecting low-level mosaic mutations.
    Tapper WJ; Foulds N; Cross NC; Aranaz P; Score J; Hidalgo-Curtis C; Robinson DO; Gibson J; Ennis S; Temple IK; Collins A
    PLoS One; 2014; 9(1):e86940. PubMed ID: 24497998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.